The World Health Organization (WHO) announced the emergency creation of a new ICD-10 code for vaping related disorders which became effective on September 29, 2019. However, the new code should not be used in the United States until April 1, 2020 at which time the new code (U07.0 “Vaping-related disorder”) should be used.
The emergency meeting of the WHO and other organizations took place in response to the reported increase of adverse health effects of vaping. This rare, mid-year addition of a new code enables health departments and government agencies to more accurately track the impact of vaping on health.
From October 1, 2019 until April 1, 2020, the following CDC coding guidelines (wording is all by the CDC) for reporting e-cigarette / vaping related disorders / conditions should be used. To enable stakeholders to better answer the question “what are the health risks of vaping”, healthcare providers should report the various health issues from vaping in the following manner.
For patients documented with electronic cigarette (e-cigarette), or vaping, product use associated lung injury (EVALI), assign the code for the specific condition, such as:
J68.0, Bronchitis and pneumonitis due to chemicals, gases, fumes and vapors; includes chemical pneumonitis
J69.1, Pneumonitis due to inhalation of oils and essences; includes lipoid pneumonia
J84.89, Other specified interstitial pulmonary disease
For patients with acute lung injury but without further documentation identifying a specific condition (pneumonitis, bronchitis), assign code:
J68.9, Unspecified respiratory condition due to chemicals, gases, fumes, and vapors
Poisoning and Toxicity Associated with E-cigarette / Vaping
Acute nicotine exposure can be toxic. Children and adults have been poisoned by swallowing, breathing, or absorbing e-cigarette liquid through their skin or eyes. For these patients assign code:
T65.291- Toxic effect of other nicotine and tobacco, accidental (unintentional); includes Toxic effect of other tobacco and nicotine NOS
For a patient with acute tetrahydrocannabinol (THC) toxicity, assign code:
T40.7X1- Poisoning by cannabis (derivatives), accidental (unintentional)
Substance Use, Abuse, and Dependence Associated with E-cigarette / Vaping
For patients with documented substance use/abuse/dependence, additional codes identifying the substance(s) used should be assigned.
When the provider documentation refers to use, abuse and dependence of the same substance (e.g. nicotine, cannabis, etc.), only one code should be assigned to identify the pattern of use based on the following hierarchy:
If both use and abuse are documented, assign only the code for abuse
If both abuse and dependence are documented, assign only the code for dependence
If use, abuse and dependence are all documented, assign only the code for dependence
If both use and dependence are documented, assign only the code for dependence.
Assign as many codes, as appropriate. Examples:
Cannabis related disorders: F12.---
Nicotine related disorders: F17.----
Specifically, for vaping of nicotine, assign code: F17.29-, Nicotine dependence, other tobacco products. Electronic nicotine delivery systems (ENDS) are non-combustible tobacco products.
Diagnosis Codes for Signs and Symptoms Associated with E-cigarette / Vaping
For patients presenting with any signs/symptoms (such as fever, etc.) and where a definitive diagnosis has not been established, assign the appropriate code(s) for each of the presenting signs and symptoms such as:
If you have questions or comments about this article please contact us. Comments that provide additional related information may be added here by our Editors.
There are several considerations to be aware of before assigning a code for lesions and soft tissue excisions.
The code selection will be determined upon the following:
Check the pathology reports, if any, to confirm Morphology (whether the neoplasm is benign, in-situ, malignant, or uncertain)
Technique
Topography (anatomic location)
The size
Tissue Level
Type of closure required
Layers ...
Proper documentation not only protects the provider, the payer, and the patient, it protects the integrity of the entire healthcare system. When it comes to coverage and documentation for durable medical, the DMEPOS supplier and staff must be familiar with the National and Local Coverage Determinations (NCDs and LCDs) as these are ...
ICD-11 is officially released, but what does that mean for diagnosis coding in the United States? What's really different? This article discusses what has been happening with ICD-11, some interesting things to note about it, as well as links to other important information.
Identifying new ways to encourage Medicare beneficiaries to schedule and attend their Annual Wellness Exam (AWE) can be difficult, but the Open Enrollment period is a prime time for every payer to identify new beneficiaries and provide a reminder to both new and existing patients that this preventive service does ...
Clinical staff (e.g., LPN, RN, MA) provide essential services which allow providers to leverage their time and improve reimbursement opportunities and run their practices more efficiently. There is, however, an ongoing question of how to appropriately bill for clinical staff time. This is really a complex question which comes down to code descriptions, federal or state licensure, AND payer policies. Failure to understand licensing and payer policies led a Connecticut provider organization down a path that ended in a $273,000 settlement with both federal and state governments.
hile many provider groups offer some imaging services in their offices, others may rely on external imaging centers. When the provider reviews images performed by an external source (e.g., independent imaging center), that is typically referred to as an overread or a re-read. Properly reporting that work depends on a variety of factors as discussed in this article.
The role of SDOH in overall patient care and outcomes has become a more common topic of discussion among healthcare providers, payers, and policymakers alike. All are attempting to identify and collect SDOH and correlate the data to patient management which is increasingly seen as necessary to address certain health disparities and identify exactly how SDOH affects patient health outcomes. Learn how to address this important subject.
